Pangea Bio
Sona Chandra is the President and Co-founder in the AI department at Pangea Bio. Prior to that, Sona founded Terra Lumina, which was eventually acquired by Pangea. With a background in healthcare strategy, operations, and product management, Sona has held positions at Oshi Health, Takeda, and Emory University. Sona has also interned at various organizations such as Medtronic and ImmunoVision. Sona holds a Master's in Public Health from Harvard University and has completed certificate programs in Product Management and Innovation & Entrepreneurship from Stanford University and The Institute of Innovation & Entrepreneurship, respectively.
Pangea Bio
Pangea develops transformative medicines for neurological disorders, deploying AI to uncover promising molecules from natural sources with prior evidence of efficacy and tolerability in humans based on traditional use.